{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:25:39Z","timestamp":1759623939409,"version":"build-2065373602"},"reference-count":34,"publisher":"Japan Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej25-0038","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T18:06:04Z","timestamp":1748887564000},"page":"1135-1142","source":"Crossref","is-referenced-by-count":0,"title":["Ectopic production of 1,25-dihydroxyvitamin D in high-grade intranasal non-intestinal-type adenocarcinoma induced hypercalcemic crisis: a case report with review of literature"],"prefix":"10.1507","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7864-7785","authenticated-orcid":false,"given":"Muneo","family":"Kawasumi","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Diabetology, Hiroshima City North Medical Center Asa Citizens Hospital, Hiroshima 731-0293, Japan"},{"name":"Department of Endocrinology and Diabetology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima 737-0023, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8562-5939","authenticated-orcid":false,"given":"Mitsunobu","family":"Kubota","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima 737-0023, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Furuie","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima 737-0023, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Kuraoka","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima 737-0023, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Wagner J, Arora S (2014) Oncologic metabolic emergencies. Emerg Med Clin North Am 32: 509\u2013525.","DOI":"10.1016\/j.emc.2014.04.003"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Stewart AF (2005) Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 352: 373\u2013379.","DOI":"10.1056\/NEJMcp042806"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Hibi M, Hara F, Tomishige H, Nishida Y, Kato T, et al. (2008) 1,25-dihydroxyvitamin D-mediated hypercalcemia in ovarian dysgerminoma. Pediatr Hematol Oncol 25: 73\u201378.","DOI":"10.1080\/08880010701774033"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Allbery SM, Swischuk LE, John SD (1998) Hypercalcemia associated with dysgerminoma: case report and imaging findings. Pediatr Radiol 28: 183\u2013185.","DOI":"10.1007\/s002470050327"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Evans KN, Taylor H, Zehnder D, Kilby MD, Bulmer JN, et al. (2004) Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: a novel form of humoral hypercalcemia of malignancy. Am J Pathol 165: 807\u2013813.","DOI":"10.1016\/S0002-9440(10)63343-3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Iqbal I, Khan MAA, Khan Y, Thalambedu N, Munir S (2019) Hypercalcemia due to paraneoplastic production of 1,25-dihydroxyvitamin D in a young female with dysgerminoma. Cureus 11: e6097.","DOI":"10.7759\/cureus.6097"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Jasti P, Lakhani VT, Woodworth A, Dahir KM (2013) Hypercalcemia secondary to gastrointestinal stromal tumors: parathyroid hormone-related protein independent mechanism? Endocr Pract 19: e158\u2013e162.","DOI":"10.4158\/EP13102.CR"},{"key":"8","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1186\/s12885-015-1823-7","volume":"15","author":"K Hygum","year":"2015","unstructured":"8 Hygum K, Wulff CN, Harsl\u00f8f T, Boysen AK, Rossen PB, et al. (2015) Hypercalcemia in metastatic GIST caused by systemic elevated calcitriol: a case report and review of the literature. BMC Cancer 15: 788.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Herrera-Mart\u00ednez Y, Contreras Gonz\u00e1lez MJ, Pedraza-Ar\u00e9valo S, Guerrero Mart\u00ednez MDC, Rodrigo Mart\u00ednez \u00c1, et al. (2021) Calcitriol-mediated hypercalcemia, somatostatin receptors expression and 25-hydroxyvitamin D(3)-1\u03b1-hydroxylase in GIST tumors. Front Endocrinol (Lausanne) 12: 812385.","DOI":"10.3389\/fendo.2021.812385"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Ogose A, Kawashima H, Morita O, Hotta T, Umezu H, et al. (2003) Increase in serum 1,25-dihydroxyvitamin D and hypercalcaemia in a patient with inflammatory myofibroblastic tumour. J Clin Pathol 56: 310\u2013312.","DOI":"10.1136\/jcp.56.4.310"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Figueiredo A, Pereira T, Cabrera R, Sim\u00f5es-Pereira J, Leite V (2023) Malignant hypercalcemia due to the ectopic production of calcitriol by an abdominal liposarcoma. Cureus 15: e33446.","DOI":"10.7759\/cureus.33446"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Saito T, Ishida M, Kusabe M, Utsumi T, Maru N, et al. (2021) Hypercalcemia owing to overproduction of 1,25-dihydroxyvitamin D(3) in fetal lung adenocarcinoma: case report. JTO Clin Res Rep 2: 100204.","DOI":"10.1016\/j.jtocrr.2021.100204"},{"key":"#cr-split#-13.1","doi-asserted-by":"crossref","unstructured":"13 Ogawa T, Miyata J, Fukunaga K, Kawana A, Inoue T (2020) Successful treatment for hypercalcemia due to cosecretion of parathyroid hormone-related protein and 1,25-dihydroxyvitamin D","DOI":"10.1155\/2020\/2475725"},{"key":"#cr-split#-13.2","unstructured":"(3) in non-small-cell lung cancer: a case report and literature review. Case Rep Pulmonol 2020: 2475725."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Ionescu F, Petrescu I, Marin M (2020) Unusual behaviour of an unusual tumour: calcitriol-induced hypercalcaemia in metastatic oesophageal neuroendocrine carcinoma. BMJ Case Rep 13: e235209.","DOI":"10.1136\/bcr-2020-235209"},{"key":"15","unstructured":"15 Zhu V, de Las Morenas A, Janicek M, Hartshorn K (2014) Hypercalcemia from metastatic pancreatic neuroendocrine tumor secreting 1,25-dihydroxyvitamin D. J Gastrointest Oncol 5: E84\u2013E87."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Shivnani SB, Shelton JM, Richardson JA, Maalouf NM (2009) Hypercalcemia of malignancy with simultaneous elevation in serum parathyroid hormone-related peptide and 1,25-dihydroxyvitamin D in a patient with metastatic renal cell carcinoma. Endocr Pract 15: 234\u2013239.","DOI":"10.4158\/EP.15.3.234"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Grote TH, Hainsworth JD (1987) Hypercalcemia and elevated serum calcitriol in a patient with seminoma. Arch Intern Med 147: 2212\u20132213.","DOI":"10.1001\/archinte.1987.00370120148027"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Osorio JC, Jones MG, Schatz-Siemers N, Tang SJ (2017) Twist on a classic: vitamin D and hypercalcaemia of malignancy. BMJ Case Rep 2017: bcr2017220819.","DOI":"10.1136\/bcr-2017-220819"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Barnes L (1986) Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol 10: 192\u2013202.","DOI":"10.1097\/00000478-198603000-00006"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Lund VJ, Chisholm EJ, Takes RP, Su\u00e1rez C, Mendenhall WM, et al. (2012) Evidence for treatment strategies in sinonasal adenocarcinoma. Head Neck 34: 1168\u20131178.","DOI":"10.1002\/hed.21770"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Bignami M, Lepera D, Volpi L, Lambertoni A, Arosio A, et al. (2018) Sinonasal non-intestinal-type adenocarcinoma: a retrospective review of 22 patients. World Neurosurg 120: e962\u2013e969.","DOI":"10.1016\/j.wneu.2018.08.201"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Jones G (2013) Extrarenal vitamin D activation and interactions between vitamin D<sub>2<\/sub>, vitamin D<sub>3<\/sub>, and vitamin D analogs. Annu Rev Nutr 33: 23\u201344.","DOI":"10.1146\/annurev-nutr-071812-161203"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Norman AW (2008) From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88: 491s\u2013499s.","DOI":"10.1093\/ajcn\/88.2.491S"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Tebben PJ, Singh RJ, Kumar R (2016) Vitamin D-mediated hypercalcemia: mechanisms, diagnosis, and treatment. Endocr Rev 37: 521\u2013547.","DOI":"10.1210\/er.2016-1070"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Cross HS, Bareis P, Hofer H, Bischof MG, Bajna E, et al. (2001) 25-Hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66: 287\u2013292.","DOI":"10.1016\/S0039-128X(00)00153-7"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Friedrich M, Rafi L, Mitschele T, Tilgen W, Schmidt W, et al. (2003) Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent Results Cancer Res 164: 239\u2013246.","DOI":"10.1007\/978-3-642-55580-0_17"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 H\u00f6baus J, Thiem U, Hummel DM, Kallay E (2013) Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis. Anticancer Agents Med Chem 13: 20\u201335.","DOI":"10.2174\/187152013804487434"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Anderson MG, Nakane M, Ruan X, Kroeger PE, Wu-Wong JR (2006) Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother Pharmacol 57: 234\u2013240.","DOI":"10.1007\/s00280-005-0059-7"},{"key":"29","unstructured":"29 Miller GJ, Stapleton GE, Hedlund TE, Moffat KA (1995) Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. Clin Cancer Res 1: 997\u20131003."},{"key":"30","unstructured":"30 Bikle DD (2000) Vitamin D: production, metabolism and mechanisms of action. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, <i>et al.<\/i> (eds) Endotext. MDText.com, Inc., South Dartmouth, USA."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Dwivedi PP, Hii CS, Ferrante A, Tan J, Der CJ, et al. (2002) Role of MAP kinases in the 1,25-dihydroxyvitamin D3-induced transactivation of the rat cytochrome P450C24 (CYP24) promoter. Specific functions for ERK1\/ERK2 and ERK5. J Biol Chem 277: 29643\u201329653.","DOI":"10.1074\/jbc.M204561200"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Wu X, Hu W, Lu L, Zhao Y, Zhou Y, et al. (2019) Repurposing vitamin D for treatment of human malignancies <i>via<\/i> targeting tumor microenvironment. Acta Pharm Sin B 9: 203\u2013219.","DOI":"10.1016\/j.apsb.2018.09.002"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Liu D, Liu L, Che X, Wu G (2025) Discovery of paradoxical genes: reevaluating the prognostic impact of overexpressed genes in cancer. Front Cell Dev Biol 13: 1525345.","DOI":"10.3389\/fcell.2025.1525345"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/10\/72_EJ25-0038\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:55:49Z","timestamp":1759550149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/10\/72_EJ25-0038\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej25-0038","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"type":"print","value":"0918-8959"},{"type":"electronic","value":"1348-4540"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ25-0038"}}